脂多糖诱导肝祖细胞分化为肌成纤维细胞构成与肝癌发生相关的微环境。
Lipopolysaccharide induces the differentiation of hepatic progenitor cells into myofibroblasts constitutes the hepatocarcinogenesis-associated microenvironment.
机构信息
Tumor Immunology and Gene Therapy Center, Shanghai Eastern Hepatobiliary Surgery Hospital, Shanghai, China.
出版信息
Cell Death Differ. 2020 Jan;27(1):85-101. doi: 10.1038/s41418-019-0340-7. Epub 2019 May 7.
Hepatocellular carcinoma (HCC) generally occurs in the presence of chronic liver injury, often as a sequela of liver fibrosis. Hepatic progenitor cells (HPCs) are known to be capable of forming both hepatocytes and cholangiocytes in chronic liver injury, which are also considered a source of myofibroblasts and tumor-initiating cells, under carcinogenic circumstances. However, the underlying mechanisms that activate HPCs to give rise to HCC are still unclear. In current study, the correlation between HPCs activation and liver fibrosis and carcinogenesis was investigated in rats and human specimens. We analyzed the role of HPCs in tumorigenesis, by transplanting exogenous HPCs in a diethylnitrosamine-induced rat HCC model. Our data indicated that HPC activation correlated with hepatic fibrosis and hepatocarcinogenesis. We further found that exogenous HPC infusion promoted liver fibrosis and hepatocarcinogenesis, while lipopolysaccharides (LPS) played an important role in this process. However, results of our study indicated that LPS did not induce HPCs to form tumor in nude mice directly. Rather, LPS induced myofibroblast-like morphology in HPCs, which enhanced the tumorigenic potential of HPCs. Further experiments showed that LPS/Toll-like receptor 4 (TLR4) signaling mediated the differentiation of HPCs into myofibroblasts and enhanced the production of interleukin-6 (IL-6) and tumor necrosis factor-α (TNF-α), which led to the aberrant expression of Ras and p53 signaling pathways in HPCs, and finally, promoted the proliferation and malignant transformation of HPCs, by long non-coding RNA regulation. Besides, examination of HCC clinical samples demonstrated that IL-6 and TNF-α production correlated with HPC activation, hepatic fibrosis, and HCC recurrence. Our study indicates that both myofibroblasts and tumor cells are derived from HPCs. HPC-derived myofibroblasts create tumor microenvironment and contribute to the proliferation and malignant transformation of HPCs. Furthermore, LPS present in the chronic liver inflammation microenvironment might play an important role in hepatocarcinogenesis, by regulating the plastic potential of HPCs.
肝细胞癌 (HCC) 通常发生在慢性肝损伤的情况下,常常是肝纤维化的后遗症。已知肝祖细胞 (HPCs) 在慢性肝损伤时能够形成肝细胞和胆管细胞,在致癌情况下,它们也被认为是肌成纤维细胞和肿瘤起始细胞的来源。然而,激活 HPCs 导致 HCC 的潜在机制仍不清楚。在目前的研究中,我们在大鼠和人类标本中研究了 HPCs 激活与肝纤维化和癌变的关系。我们通过在二乙基亚硝胺诱导的大鼠 HCC 模型中移植外源性 HPCs 来分析 HPCs 在肿瘤发生中的作用。我们的数据表明,HPC 激活与肝纤维化和肝癌发生相关。我们进一步发现,外源性 HPC 输注促进肝纤维化和肝癌发生,而脂多糖 (LPS) 在这一过程中发挥重要作用。然而,我们的研究结果表明 LPS 并没有直接诱导 HPCs 在裸鼠中形成肿瘤。相反,LPS 诱导 HPCs 形成肌成纤维细胞样形态,增强了 HPCs 的致瘤潜能。进一步的实验表明,LPS/Toll 样受体 4 (TLR4) 信号介导 HPCs 向肌成纤维细胞分化,并增强白细胞介素-6 (IL-6) 和肿瘤坏死因子-α (TNF-α) 的产生,导致 HPCs 中 Ras 和 p53 信号通路的异常表达,最终通过长链非编码 RNA 调控促进 HPCs 的增殖和恶性转化。此外,对 HCC 临床样本的检查表明,IL-6 和 TNF-α 的产生与 HPC 激活、肝纤维化和 HCC 复发相关。我们的研究表明,肌成纤维细胞和肿瘤细胞均来源于 HPCs。HPC 衍生的肌成纤维细胞创造肿瘤微环境,促进 HPCs 的增殖和恶性转化。此外,慢性肝炎症微环境中的 LPS 可能通过调节 HPCs 的可塑性在肝癌发生中发挥重要作用。
相似文献
Stem Cell Reports. 2016-12-1
J Nanobiotechnology. 2022-2-14
Proc Natl Acad Sci U S A. 2020-3-5
Scand J Gastroenterol. 2014-1
引用本文的文献
Iran J Basic Med Sci. 2025
Nat Rev Gastroenterol Hepatol. 2025-7-7
Signal Transduct Target Ther. 2024-3-25
Genes Dis. 2023-7-16
本文引用的文献
Lab Anim. 2015-4
Int J Clin Exp Pathol. 2014-9-15